Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, announced that Randall ...

Measles is making a troubling comeback in the U.S., driven by declining vaccination rates and rising vaccine hesitancy.

The Cleveland Clinic notes that there is no cure for measles, and measles just has to "run its course." However, the best ...

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces positive in-vivo proof-of-concept data for a powder-based intranasal vaccine candidate formulated with the AmorphOX technology.

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

With a rising measles outbreak in the U.S., experts stress the importance of vaccination. While most individuals are ...

A colleague who spends summers in New Mexico, where there is an ongoing measles outbreak, had a question for Healio’s ...

A board-certified family medicine physician explains what a measles vaccine booster is, who should receive it as an adult, and why they may wish to consider it.

Chiropractic physician Dr. Cathleen Gerenger joined Gayle Guyardo, host of the global health and wellness show Bloom, to discuss long COVID symptoms and the findings of a ...

Vaxcyte is awaiting data from another vaccine candidate for invasive pneumococcal disease (IPD) before advancing to Phase III ...

The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings with increased risk or high transmission. We recommend additional studies to ...